Acasti Pharma Shares Outstanding 2014-2023 | ACST
Acasti Pharma shares outstanding from 2014 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Acasti Pharma Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
7 |
| 2022 |
6 |
| 2021 |
2 |
| 2020 |
2 |
| 2019 |
1 |
| 2018 |
0 |
| 2017 |
0 |
| 2016 |
0 |
| 2015 |
0 |
| 2015 |
|
| 2014 |
0 |
| 2014 |
|
| 2013 |
0 |
| 2013 |
|
Acasti Pharma Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-12-31 |
12 |
| 2023-09-30 |
8 |
| 2023-06-30 |
7 |
| 2023-03-31 |
7 |
| 2022-12-31 |
7 |
| 2022-09-30 |
7 |
| 2022-06-30 |
7 |
| 2022-03-31 |
6 |
| 2021-12-31 |
7 |
| 2021-09-30 |
5 |
| 2021-06-30 |
4 |
| 2021-03-31 |
2 |
| 2020-12-31 |
2 |
| 2020-09-30 |
2 |
| 2020-06-30 |
2 |
| 2020-03-31 |
2 |
| 2019-12-31 |
2 |
| 2019-09-30 |
2 |
| 2019-06-30 |
2 |
| 2019-03-31 |
1 |
| 2018-12-31 |
1 |
| 2018-09-30 |
1 |
| 2018-06-30 |
1 |
| 2018-03-31 |
0 |
| 2017-12-31 |
0 |
| 2017-09-30 |
0 |
| 2017-06-30 |
0 |
| 2017-02-28 |
0 |
| 2016-11-30 |
0 |
| 2016-08-31 |
0 |
| 2016-05-31 |
0 |
| 2016-03-31 |
0 |
| 2016-02-29 |
|
| 2015-12-31 |
0 |
| 2015-09-30 |
2 |
| 2015-06-30 |
0 |
| 2015-03-31 |
0 |
| 2014-12-31 |
0 |
| 2014-09-30 |
0 |
| 2014-06-30 |
0 |
| 2014-03-31 |
0 |
| 2014-02-28 |
|
| 2013-12-31 |
0 |
| 2013-09-30 |
0 |
| 2013-06-30 |
0 |
| 2013-03-31 |
0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.027B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
